Creative Medical Technology (NASDAQ:CELZ) Stock Price Crosses Below 50 Day Moving Average – What’s Next?

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ)’s stock price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.50 and traded as low as $0.62. Creative Medical Technology shares last traded at $0.65, with a volume of 249,764 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut shares of Creative Medical Technology from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Creative Medical Technology has a consensus rating of “Reduce”.

Creative Medical Technology Trading Down 2.1%

The firm has a fifty day simple moving average of $1.50 and a 200-day simple moving average of $1.86. The stock has a market cap of $3.08 million, a price-to-earnings ratio of -0.30 and a beta of 1.95.

Creative Medical Technology (NASDAQ:CELZ) last released its earnings results on Friday, May 8th. The company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.01. On average, equities analysts predict that Creative Medical Technology Holdings, Inc. will post -1.14 earnings per share for the current fiscal year.

Institutional Trading of Creative Medical Technology

A hedge fund recently bought a new position in Creative Medical Technology stock. Jane Street Group LLC bought a new stake in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 30,205 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned 1.17% of Creative Medical Technology at the end of the most recent quarter. Institutional investors and hedge funds own 1.42% of the company’s stock.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc (NASDAQ: CELZ) is a clinical?stage biotechnology company focused on the development, manufacture and commercialization of exosome?based therapies derived from human bone marrow mesenchymal stem cells. The company’s proprietary exosome platform is being investigated for applications in regenerative medicine, aesthetic dermatology, wound healing and anti?inflammatory treatments. Creative Medical leverages cGMP manufacturing processes to produce sterile, cell?free exosome formulations designed to support tissue repair and cellular rejuvenation.

The company’s lead product candidates include XoFlo, an exosome enrichment product intended for use in musculoskeletal and soft tissue injuries, and specialized formulations targeting skin rejuvenation and scar reduction.